Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Yuan, Xiaoliang ^a,d   Zhang, Tiantuo ^a   Kawakami, Kazuyoshi ^b   Zhu, Jiaxin ^a   Zheng, Wenzheng ^a   Li, Hongtao ^a   Deng, Guofang ^c   Tu, Shaohua ^c   Liu, Weiyou ^d  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Jiang Xi Chest Hospital   (China)

^d GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Extensively drug resistant; MIRU VNTR; Multidrug resistant; Mycobacterium tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; ERYTHROMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CHINA; CLINICAL FEATURE; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE DELETION; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RETROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; VARIABLE NUMBER OF TANDEM REPEAT;

ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHINA; CLUSTER ANALYSIS; COMORBIDITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; MALE; MICROBIAL SENSITIVITY TESTS; MINISATELLITE REPEATS; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84880001455     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-315     Document Type: Article

References (41)

1. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, Van SD, Jensen P, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843. 10.1016/S0140-6736(10)60410-2, 20488523.
2. World Health Organization Global Tuberculosis control: WHO report 2011 2011, Geneva, Switzerland: WHO/HTM/TB/2011.16. World Health Organization, World Health Organization.
3. Yang Y, Li X, Zhou F, Jin Q, Gao L. Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis. PLoS One 2011, 6:e20343. 10.1371/journal.pone.0020343, 3108589, 21674033.
4. Zhou A, Nawaz M, Xue X, Karakousis PC, Yao Y, Xu J. Molecular genotyping of Mycobacterium tuberculosis in Xi'an, China, using MIRU-VNTR typing. Int J Tuberc Lung Dis 2011, 15:517-522. 10.5588/ijtld.10.0495, 21396212.
5. Alonso-Rodriguez N, Martinez-Lirola M, Herranz M, Sanchez-Benitez M, Barroso P, Bouza E, de Viedma DG. Evaluation of the new advanced 15-loci MIRU-VNTR genotyping tool in Mycobacterium tuberculosis molecular epidemiology studies. BMC Microbiol 2008, 8:34. 10.1186/1471-2180-8-34, 2291470, 18339198.
6. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, Van DH, Roring S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006, 44:4498-4510. 10.1128/JCM.01392-06, 1698431, 17005759.
7. Wang J, Liu Y, Zhang CL, Ji BY, Zhang LZ, Shao YZ, Jiang SL, Suzuki Y, Nakajima C, Fan CL, et al. Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China. J Clin Microbiol 2011, 49:1354-1362. 10.1128/JCM.02274-10, 3122865, 21325562.
8. Christianson S, Wolfe J, Orr P, Karlowsky J, Levett PN, Horsman GB, Thibert L, Tang P, Sharma MK. Evaluation of 24 locus MIRU-VNTR genotyping of Mycobacterium tuberculosis isolates in Canada. Tuberculosis (Edinb) 2010, 90:31-38.
9. Zhang L, Chen J, Shen X, Gui X, Mei J, Deriemer K, Gao Q. Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol Lett 2008, 282:22-31. 10.1111/j.1574-6968.2008.01081.x, 18336551.
10. Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, Tu S. Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol 2012, 50:2404-2413. 10.1128/JCM.06860-11, 3405621, 22553245.
11. Dickman KR, Nabyonga L, Kateete DP, Katabazi FA, Asiimwe BB, Mayanja HK, Okwera A, Whalen C, Joloba ML. Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala Uganda. BMC Infect Dis 2010, 10:349. 10.1186/1471-2334-10-349, 3004912, 21143966.
12. Vadwai V, Shetty A, Supply P, Rodrigues C. Evaluation of 24-locus MIRU-VNTR in extrapulmonary specimens: study from a tertiary centre in Mumbai. Tuberculosis (Edinb) 2012, 92:264-272.
13. World Health Organization Guidelines for surveillance of drug resistance in tuberculosis 2009, Geneva, Switzerland: WHO/HTM/TB/2009.422. World Health Organization, 4, World Health Organization.
14. Heysell SK, Thomas TA, Gandhi NR, Moll AP, Eksteen FJ, Coovadia Y, Roux L, Babaria P, Lalloo U, Friedland G, et al. Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study. BMC Infect Dis 2010, 10:344. 10.1186/1471-2334-10-344, 3016377, 21134279.
15. Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, Spector S, Roscigno G, Nkengasong J. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev 2011, 24:314-350. 10.1128/CMR.00059-10, 3122496, 21482728.
16. Zhao M, Li X, Xu P, Shen X, Gui X, Wang L, Deriemer K, Mei J, Gao Q. Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 2009, 4:e4370. 10.1371/journal.pone.0004370, 2631152, 19190774.
17. Somerville W, Thibert L, Schwartzman K, Behr MA. Extraction of Mycobacterium tuberculosis DNA: a question of containment. J Clin Microbiol 2005, 43:2996-2997. 10.1128/JCM.43.6.2996-2997.2005, 1151963, 15956443.
18. Chen J, Tsolaki AG, Shen X, Jiang X, Mei J, Gao Q. Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2007, 87:446-449.
19. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739. 10.1093/molbev/msr121, 3203626, 21546353.
20. Allix-Beguec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008, 46:2692-2699. 10.1128/JCM.00540-08, 2519508, 18550737.
21. Mazars E, Lesjean S, Banuls AL, Gilbert M, Vincent V, Gicquel B, Tibayrenc M, Locht C, Supply P. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA 2001, 98:1901-1906. 10.1073/pnas.98.4.1901, 29354, 11172048.
22. Sola C, Filliol I, Legrand E, Lesjean S, Locht C, Supply P, Rastogi N. Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect Genet Evol 2003, 3:125-133. 10.1016/S1567-1348(03)00011-X, 12809807.
23. World Health Organization Treatment of tuberculosis: guidelines 2010, Geneva, Switzerland: WHO/HTM/TB/2009.420. World Health Organization, 4, World Health Organization.
24. Wang D, Yang C, Kuang T, Lei H, Meng X, Tong A, He J, Jiang Y, Guo F, Dong M. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study. Jpn J Infect Dis 2010, 63:368-371.
25. Gao Q, Li X. Transmission of MDR tuberculosis. Drug Discovery Today: Disease Mechanism 2010, 7:e61-61e65.
26. Sun Q, Meng Q, Yip W, Yin X, Li H. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis 2008, 12:625-630.
27. Murase Y, Maeda S, Yamada H, Ohkado A, Chikamatsu K, Mizuno K, Kato S, Mitarai S. Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 2010, 16:948-954. 10.3201/eid1606.091844, 3086214, 20507745.
28. Liu Q, Yang D, Xu W, Wang J, LV B, Shao Y, Song H, Li G, Dong H, Wan K, et al. Molecular typing of Mycobacterium tuberculosis isolates circulating in Jiangsu province, China. BMC Infect Dis 2011, 11:288. 10.1186/1471-2334-11-288, 3215657, 22026819.
29. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746. 10.1016/S1473-3099(09)70282-8, 2945809, 19926034.
30. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001, 120:1514-1519. 10.1378/chest.120.5.1514, 11713128.
31. Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 2008, 40:888-893. 10.1080/00365540802342372, 2887603, 18728934.
32. Chang JT, Dou HY, Yen CL, Wu YH, Huang RM, Lin HJ, Su IJ, Shieh CC. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011, 110:372-381. 10.1016/S0929-6646(11)60055-7, 21741005.
33. Singla R, Khan N. Does diabetes predispose to the development of multidrug-resistant tuberculosis. Chest 2003, 123:308-309. 10.1378/chest.123.1.308, 12527642.
34. Tanrikulu AC, Hosoglu S, Ozekinci T, Abakay A, Gurkan F. Risk factors for drug resistant tuberculosis in southeast Turkey. Trop Doct 2008, 38:91-93. 10.1258/td.2007.070131, 18453496.
35. Suarez-Garcia I, Rodriguez-Blanco A, Vidal-Perez JL, Garcia-Viejo MA, Jaras-Hernandez MJ, Lopez O, Noguerado-Asensio A. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis 2009, 28:325-330. 10.1007/s10096-008-0627-y, 18830725.
36. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101. 10.1056/NEJMoa0908292, 20335585.
37. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006, 6:23. 10.1186/1471-2180-6-23, 1468417, 16519816.
38. Jiao WW, Mokrousov I, Sun GZ, Guo YJ, Vyazovaya A, Narvskaya O, Shen AD. Evaluation of new variable-number tandem-repeat systems for typing Mycobacterium tuberculosis with Beijing genotype isolates from Beijing, China. J Clin Microbiol 2008, 46:1045-1049. 10.1128/JCM.01869-07, 2268385, 18199785.
39. He GX, Wang HY, Borgdorff MW, Van SD, der Werf MJ V, Liu ZM, Li XZ, Guo H, Zhao YL, Varma JK, et al. Multidrug-resistant tuberculosis, People's Republic of China, 2007-2009. Emerg Infect Dis 2011, 17:1831-1838. 10.3201/eid1710.110546, 3310678, 22000352.
40. Blower SM, Chou T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat Med 2004, 10:1111-1116. 10.1038/nm1102, 15378053.
41. Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999, 149:366-371. 10.1093/oxfordjournals.aje.a009822, 10025480.